Our goal is to introduce and increase awareness of strategies for dual elimination, or the elimination of MTCT of HIV and syphilis, among healthcare providers in Sub-Saharan Africa and, therefore, encourage the provider-initiated provision of HIV and syphilis testing and treatments in antenatal care clinics in this region.
Jeffrey D. Klausner, MD MPH, is a Professor of Medicine in the Division of Infectious Diseases, Department of Medicine, of the David Geffen School of Medicine at the University of California, Los Angeles (UCLA). Dr. Klausner’s research interests are in applied epidemiology and the prevention and control
of infectious disease s of public health importance like HIV, STDs, TB and
cryptococcus. Dr. Klausner has a particular interest in the use of technology—information, digital, and laboratory—to facilitate access to treatment for disadvantaged populations. Dr. Klausner has been funded by the NIH, CDC, private pharmaceutical and test manufacturers to study the benefits of new ways to find and treat infectious diseases. Dr. Klausner has been a leading advocate in the use of medical male circumcision for HIV and STD prevention. Dr. Klausner is a frequent advisor to the CDC, NIH and WHO and a popular public speaker. Dr. Klausner is a highly sought after mentor who has trained dozens of fellows, residents and students of medicine and public health.
Claire C. Bristow, PhD MPH MSc, is an epidemiologist with research experience on sexually transmitted infections (STIs), tuberculosis and HIV. She is specifically interested in the use, development, and application of innovative diagnostic strategies to better understand the epidemiology of STIs. Currently, Dr. Bristow is an Assistant Professor in the Division of Infectious Diseases and Global Public Health in the Department of Medicine at the University of California, San Diego where she conducts projects of implementation science and infectious disease epidemiology. From 2009 – 2012, she served as a field epidemiologist for the U.S. Centers for Disease Control and Prevention in the Division of Tuberculosis Elimination and the Global AIDS Program in South Africa. Dr. Bristow specializes in point-of-care and molecular laboratory diagnostics, development and implementation of new screening strategies. In this work, and in partnership with Dr. Klausner, she has developed testing protocols for field studies in Mexico, Peru, Botswana and Haiti.